These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin. Brown CH; Crowe MF J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167 [TBL] [Abstract][Full Text] [Related]
10. Regulation of plasma factor XIII binding to fibrin in vitro. Greenberg CS; Dobson JV; Miraglia CC Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926 [TBL] [Abstract][Full Text] [Related]
11. Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers--a thiol enhanced process. Procyk R; Adamson L; Block M; Blombäck B Thromb Res; 1985 Dec; 40(6):833-52. PubMed ID: 2868545 [TBL] [Abstract][Full Text] [Related]
12. Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin. Procyk R; Blomback B Biochim Biophys Acta; 1988 Nov; 967(2):304-13. PubMed ID: 2903773 [TBL] [Abstract][Full Text] [Related]
13. Human fibrinogen and asialo-fibrinogen: a comparison of coagulation parameters. Gentry PA; Alexander B Arch Biochem Biophys; 1976 Mar; 173(1):50-7. PubMed ID: 176955 [No Abstract] [Full Text] [Related]
15. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation]. Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289 [TBL] [Abstract][Full Text] [Related]
16. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release. Lane DA; Cuddigan B; VanRoss M; Kakkar VV Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460 [TBL] [Abstract][Full Text] [Related]
18. Polymerization and gelation of fibrinogen in D2O. Larsson U Eur J Biochem; 1988 May; 174(1):139-44. PubMed ID: 3371358 [TBL] [Abstract][Full Text] [Related]
19. Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis. Vaziri ND; Gonzales E; Barton CH; Chen HT; Nguyen Q; Arquilla M J Lab Clin Med; 1991 Feb; 117(2):152-6. PubMed ID: 1993857 [TBL] [Abstract][Full Text] [Related]
20. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Janus TJ; Lewis SD; Lorand L; Shafer JA Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]